CHRISTOPHER MANUS, M.D.
Hematology & Oncology Physician · BARTLESVILLE, OK
Individual Active NPI 1629282389
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 736 | 236,550 | $11,083,541 | $4,465,303 | $3,550,304 |
| 2023 | 749 | 240,750 | $10,966,719 | $4,308,431 | $3,424,340 |
| 2022 | 920 | 259,556 | $11,184,055 | $4,294,993 | $3,428,402 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 49,500 | $1 | $1 |
| J1627 | Injection, granisetron, extended-release, 0.1 mg | 19,500 | $5 | $4 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 18,100 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 13,600 | $56 | $45 |
| J9267 | Injection, paclitaxel, 1 mg | 6,206 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 5,700 | $0 | $0 |
| J0185 | Injection, aprepitant, 1 mg | 4,940 | $2 | $1 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 4,556 | $0 | $0 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 3,960 | $26 | $20 |
| J0897 | Injection, denosumab, 1 mg | 2,520 | $26 | $21 |
| 36415 | Insertion of needle into vein for collection of blood sample | 1,953 | $9 | $9 |
| J0640 | Injection, leucovorin calcium, per 50 mg | 935 | $5 | $4 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 27660 | OK |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Oklahoma
- NPI 1215301346
- NPI 1184948234
- NPI 1659755387
- NPI 1013058452
- NPI 1528499712
- NPI 1154434405
- NPI 1265813513
- NPI 1235397654
See all Hematology & Oncology Physician providers in Oklahoma →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.